lisinopril/hctz
Generic: lisinopril/hctz
Labeler: direct_rxDrug Facts
Product Profile
Brand Name
lisinopril/hctz
Generic Name
lisinopril/hctz
Labeler
direct_rx
Dosage Form
TABLET
Routes
Active Ingredients
hydrochlorothiazide 12.5 mg/1, lisinopril 20 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
72189-651
Product ID
72189-651_4510c108-2684-f505-e063-6394a90ab0a4
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA076230
Listing Expiration
2026-12-31
Marketing Start
2025-12-03
Pharmacologic Class
Established (EPC)
Chemical Structure
Physiologic Effect
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
72189651
Hyphenated Format
72189-651
Supplemental Identifiers
RxCUI
UNII
NUI
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
lisinopril/hctz (source: ndc)
Generic Name
lisinopril/hctz (source: ndc)
Application Number
ANDA076230 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 12.5 mg/1
- 20 mg/1
Packaging
- 30 TABLET in 1 BOTTLE (72189-651-30)
Packages (1)
Ingredients (2)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "4510c108-2684-f505-e063-6394a90ab0a4", "openfda": {"nui": ["N0000175359", "N0000175419", "M0471776"], "unii": ["0J48LPH2TH", "E7199S1YWR"], "rxcui": ["197886"], "spl_set_id": ["4510c108-2683-f505-e063-6394a90ab0a4"], "pharm_class_cs": ["Thiazides [CS]"], "pharm_class_pe": ["Increased Diuresis [PE]"], "pharm_class_epc": ["Thiazide Diuretic [EPC]"], "manufacturer_name": ["Direct_Rx"]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE (72189-651-30)", "package_ndc": "72189-651-30", "marketing_start_date": "20251203"}], "brand_name": "Lisinopril/HCTZ", "product_id": "72189-651_4510c108-2684-f505-e063-6394a90ab0a4", "dosage_form": "TABLET", "pharm_class": ["Angiotensin Converting Enzyme Inhibitor [EPC]", "Angiotensin-converting Enzyme Inhibitors [MoA]", "Increased Diuresis [PE]", "Thiazide Diuretic [EPC]", "Thiazides [CS]"], "product_ndc": "72189-651", "generic_name": "Lisinopril/HCTZ", "labeler_name": "Direct_Rx", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Lisinopril/HCTZ", "active_ingredients": [{"name": "HYDROCHLOROTHIAZIDE", "strength": "12.5 mg/1"}, {"name": "LISINOPRIL", "strength": "20 mg/1"}], "application_number": "ANDA076230", "marketing_category": "ANDA", "marketing_start_date": "20251203", "listing_expiration_date": "20261231"}